Halozyme Therapeutics
HALO
#2250
Rank
A$12.08 B
Marketcap
A$101.92
Share price
1.06%
Change (1 day)
22.34%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$0.72 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.39 Billion. a decrease over its 2024 earnings that were of A$0.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$0.66 B-16.2%
2024 A$0.79 B59.94%
2023 A$0.49 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$87.84 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$45.96 Million-52.86%
2014 -A$97.5 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$76.37 Million169.94%
2011 -A$28.29 Million-63.44%
2010 -A$77.37 Million-7.19%
2009 -A$83.36 Million15.91%
2008 -A$71.92 Million83.89%
2007 -A$39.11 Million78.1%
2006 -A$21.96 Million16%
2005 -A$18.93 Million45.24%
2004 -A$13.04 Million682.42%
2003 -A$1.67 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.04 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.10 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.38 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.92 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.73 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$2 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA